Our study suggested that one consequence of DNMT1 targeting by gDEC is the upregulation of KMTs, which could mediate the activation of tumor-suppressing programs and contribute to the overall prostate cancer phenotype change and anticancer effect. Here, DNMT1 is linked to prostate carcinoma.